Read More

Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program

Israeli psychedelics biotech Clearmind Medicine (NASDAQ: CMND) has inked a research agreement with Johns Hopkins University School of Medicine (JHU) to conduct the first-in-human Phase I/IIa clinical trial on its proprietary MEAI-based compound CMND-100 for the potential treatment of Alcoho

CMND

Read More

Nasdaq Down 50 Points; US Trade Deficit Widens In July

U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 50 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.27% to 34,547.44 while the NASDAQ fell 0.36% to 13,970.92. The S&P 500, also fell, dropping, 0.34% to 4,481.74.

EZGO